MARKET

TIL

TIL

Instil Bio, Inc.
NASDAQ
7.76
+0.30
+4.02%
After Hours: 7.76 0 0.00% 16:10 02/06 EST
OPEN
7.49
PREV CLOSE
7.46
HIGH
7.82
LOW
7.49
VOLUME
92.76K
TURNOVER
--
52 WEEK HIGH
42.79
52 WEEK LOW
5.67
MARKET CAP
52.63M
P/E (TTM)
-0.6811
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at TIL last week (0126-0130)?
Weekly Report · 5d ago
Weekly Report: what happened at TIL last week (0119-0123)?
Weekly Report · 01/26 10:04
Weekly Report: what happened at TIL last week (0112-0116)?
Weekly Report · 01/19 10:09
Weekly Report: what happened at TIL last week (0105-0109)?
Weekly Report · 01/12 10:09
Instil Bio Cut to Neutral From Buy by HC Wainwright & Co.
Dow Jones · 01/07 14:44
HC Wainwright & Co. Downgrades Instil Bio to Neutral
Benzinga · 01/07 14:34
Instil Bio downgraded to Neutral from Buy at H.C. Wainwright
TipRanks · 01/07 14:07
Instil Bio (TIL) was downgraded to a Hold Rating at H.C. Wainwright
TipRanks · 01/07 14:07
More
About TIL
Instil Bio, Inc. is a clinical-stage biopharmaceutical company focused on developing a pipeline of novel therapies. The Company seeks to in-license/acquire and develop novel therapeutic candidates in diseases with significant unmet medical need. The Company’s subsidiary, Axion Bio, Inc., in-licensed certain bispecific antibodies, including AXN-2510/IMM2510 and AXN-27M/IMM27M, a monoclonal antibody targeting cytotoxic T-lymphocyte associated antigen 4, or CTLA-4. AXN-2510/IMM2510, the lead in-licensed product candidate, is a novel and differentiated PD-L1xVEGF bispecific antibody in development for the treatment of multiple solid tumor cancers. AXN-27M/IMM27M is an antibody-dependent cellular cytotoxicity-enhanced monoclonal antibody targeting CTLA-4, which has been designed to promote intratumoral regulatory T cell depletion to enhance the efficacy and reduce the toxicity associated with first-generation anti-CTLA-4 antibodies.

Webull offers Instil Bio Inc stock information, including NASDAQ: TIL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TIL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TIL stock methods without spending real money on the virtual paper trading platform.